We currently run five labs. We are willing to partner with you to expand our horizon.
Welcome to UB-CeDD
WHAT WE DO
Founded in 2022, UB-CeDD is a community of medicinal chemists, AI/ML experts, microbiologists, biochemists, natural product experts and plant taxonomists whose quest is to discover new therapies for diseases that primarily affect Africans and are based on naturally occurring compounds from African medicinal plants and other African sources. The research center is being set up with seed funding from the Bill & Melinda Gates Foundation through a Calestous Juma Science Leadership Fellowship awarded in 2021 to Fidele Ntie-Kang, the vision bearer of the center.
If lions allowed their untold exploits to be recounted by the hunters, the history books would only contain one-sided records.
We basically offer three kinds of services
Research in Drug Discovery
Main Focus on Anti-infective Agents
Our projects range from infectious disease areas to non-communicable diseases. Our approach includes the identification of suitable drug targets for these diseases and/or a suitably acting small molecules. We then use a panel of in silico (computer-based) approaches and in vitro validation methods to find lead compounds, optimize them and develop them as clinical candidates.
Training in Drug Discovery
MSc, PhD, Internships, Workshops, …
We currently supervise internships and thesis projects in five drug discovery areas:
- Computer-aided drug design.
- Synthesis of new chemical entities.
- Identification of modes of action of new and known natural products.
- Testing of new compound activities.
- Determination of metabolic stability of drug leads.
You might want to partner with us to develop new ideas or explore existing ideas. We have experience handling outsourced big data and we have a team of dedicated staff who are willing to explore new ideas and switch roles. We want to explore new drug targets, new small lead compounds, unexplored plant species, develop new computer modeling approaches, as well as synthetic chemistry and chemical library generation and develop new partnerships.